1. Iron Metabolism in the Tumor Microenvironment: Contributions of Innate Immune Cells
   Wei Liang et al, 2021, Frontiers in Immunology CrossRef
2. Ferroportin and FBXL5 as Prognostic Markers in Advanced Stage Clear Cell Renal Cell Carcinoma
   Cheol Keun Park et al, 2021, Cancer Research and Treatment CrossRef
3. Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma
   Tianyu Dong et al, 2022, Frontiers in Oncology CrossRef
4. Iron Metabolism in Prostate Cancer; From Basic Science to New Therapeutic Strategies
   Driton Vela, 2018, Frontiers in Oncology CrossRef
5. Current understanding of ferroptosis in the progression and treatment of pancreatic cancer
   Shi Dong et al, 2021, Cancer Cell International CrossRef
6. Hepcidin Is a Valuable Therapeutic Target for Colorectal Cancer
   Rachele Frascatani et al, 2024, Cancers CrossRef
7. An Integrated Systematic Analysis and the Clinical Significance of Hepcidin in Common Malignancies of the Male Genitourinary System
   Xiaogang Wang et al, 2022, Frontiers in Genetics CrossRef
8. Hepcidin Upregulation in Lung Cancer: A Potential Therapeutic Target Associated With Immune Infiltration
   Yumei Fan et al, 2021, Frontiers in Immunology CrossRef
9. HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling
   Vincenzo Formica et al, 2023, British Journal of Cancer CrossRef
10. Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology
    Rikki A. M. Brown et al, 2020, Frontiers in Oncology CrossRef